A DNA scaffold that carries HIV vaccine proteins into the body sharpens the immune response against the virus.
Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer inhibitor (INSTI) single tablet treatment for HIV, among growing concern for ...
AZoLifeSciences on MSN
DNA origami vaccine scaffolds sharpen immune targeting against HIV
One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...
YouTube on MSN
How HIV first started in humans
The devastating aids epidemic has claimed hundreds of thousands of lives—did you know that a sick chimpanzee is part of what ...
Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with drug-resistant infections in 2022. While there is still no vaccine for the ...
Gloved fingers hold a labeled vial of lenacapavir, a clear, yellowish liquid. Lenacapavir (shown) is an antiretroviral medication used to help prevent and treat HIV. Credit: Associated Press While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results